With all these benefits of BYOD and the recent technological advances that have taken place, regulatory, logistic, data privacy, and security questions remain. What sort of documentation will the FDA require to support BYOD-derived data? Does BYOD adequately protect patient data? Will BYOD work for a global Phase III study?
This webinar will address these considerations as well as help clinical trial sponsors develop a clear path to GO BYOD.